89 related articles for article (PubMed ID: 8468245)
1. Synthesis of the metabolite N-hydroxy-desferrioxamine B.
Roggo BE; Peter HH
J Antibiot (Tokyo); 1993 Feb; 46(2):294-9. PubMed ID: 8468245
[TBL] [Abstract][Full Text] [Related]
2. Ferric ion sequestering agents. 11. Synthesis and kinetics of iron removal from transferrin of catechoyl derivatives of desferrioxamine B.
Rodgers SJ; Raymond KN
J Med Chem; 1983 Mar; 26(3):439-42. PubMed ID: 6827563
[No Abstract] [Full Text] [Related]
3. Analogues of desferrioxamine B (DFOB) with new properties and new functions generated using precursor-directed biosynthesis.
Telfer TJ; Richardson-Sanchez T; Gotsbacher MP; Nolan KP; Tieu W; Codd R
Biometals; 2019 Jun; 32(3):395-408. PubMed ID: 30701380
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Mn(III) complexes of linear and cyclic desferrioxamines as mimics of superoxide dismutase activity.
Faulkner KM; Stevens RD; Fridovich I
Arch Biochem Biophys; 1994 May; 310(2):341-6. PubMed ID: 8179317
[TBL] [Abstract][Full Text] [Related]
5. Novel desferrioxamine derivatives synthesized using the secondary metabolism-specific nitrous acid biosynthetic pathway in Streptomyces davawensis.
Hagihara R; Katsuyama Y; Sugai Y; Onaka H; Ohnishi Y
J Antibiot (Tokyo); 2018 Nov; 71(11):911-919. PubMed ID: 30120394
[TBL] [Abstract][Full Text] [Related]
6. An improved animal model for studying desferrioxamine.
Steward A; Williamson I; Madigan T; Bretnall A; Hassan IF
Br J Haematol; 1996 Dec; 95(4):654-9. PubMed ID: 8982041
[TBL] [Abstract][Full Text] [Related]
7. Structural alterations in desferrioxamine compatible with iron clearance in animals.
Bergeron RJ; Liu ZR; McManis JS; Wiegand J
J Med Chem; 1992 Dec; 35(25):4739-44. PubMed ID: 1469701
[TBL] [Abstract][Full Text] [Related]
8. Engineering a cleavable disulfide bond into a natural product siderophore using precursor-directed biosynthesis.
Richardson-Sanchez T; Codd R
Chem Commun (Camb); 2018 Aug; 54(70):9813-9816. PubMed ID: 30106398
[TBL] [Abstract][Full Text] [Related]
9. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation.
Reeder BJ; Wilson MT
Chem Res Toxicol; 2005 Jun; 18(6):1004-11. PubMed ID: 15962935
[TBL] [Abstract][Full Text] [Related]
10. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects.
Summers MR; Jacobs A; Tudway D; Perera P; Ricketts C
Br J Haematol; 1979 Aug; 42(4):547-55. PubMed ID: 476006
[TBL] [Abstract][Full Text] [Related]
11. Development of an intravenous desferrioxamine mesylate treatment protocol for swine: monitoring of desferrioxamine and metabolites by high-performance liquid chromatography.
Fisher EA; McLachlan DR; Kruck TP; Mustard RA
Pharmacology; 1990; 41(5):263-71. PubMed ID: 2092330
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic analysis of desferrioxamine. Pharmacokinetic and metabolic studies.
Kruck TP; Teichert-Kuliszewska K; Fisher E; Kalow W; McLachlan DR
J Chromatogr; 1988 Dec; 433():207-16. PubMed ID: 3235548
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of hydroxamate-based iron chelators.
Bergeron RJ; Wiegand J; McManis JS; Perumal PT
J Med Chem; 1991 Nov; 34(11):3182-7. PubMed ID: 1956036
[TBL] [Abstract][Full Text] [Related]
14. Ability to determine the desferrioxamine-chelatable iron fractions of nontransferrin-bound iron using HPLC.
Koba M; Słomka A; Bączek T; Marszałł MP; Zekanowska E
J Sep Sci; 2013 Feb; 36(4):665-9. PubMed ID: 23355397
[TBL] [Abstract][Full Text] [Related]
15. Degradation of desferrioxamines by Azospirillum irakense: assignment of metabolites by HPLC/electrospray mass spectrometry.
Winkelmann G; Busch B; Hartmann A; Kirchhof G; Süssmuth R; Jung G
Biometals; 1999 Sep; 12(3):255-64. PubMed ID: 10581690
[TBL] [Abstract][Full Text] [Related]
16. Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.
Gotsbacher MP; Telfer TJ; Witting PK; Double KL; Finkelstein DI; Codd R
Metallomics; 2017 Jul; 9(7):852-864. PubMed ID: 28466891
[TBL] [Abstract][Full Text] [Related]
17. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.
Loyevsky M; Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
J Clin Invest; 1993 Jan; 91(1):218-24. PubMed ID: 8423220
[TBL] [Abstract][Full Text] [Related]
18. Chelate mediated transfer of iron from transferrin to desferrioxamine.
Pollack S; Aisen P; Lasky FD; Vanderhoff G
Br J Haematol; 1976 Oct; 34(2):231-5. PubMed ID: 974036
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the desferrioxamine gene cluster of Streptomyces coelicolor is mediated by binding of DmdR1 to an iron box in the promoter of the desA gene.
Tunca S; Barreiro C; Sola-Landa A; Coque JJ; Martín JF
FEBS J; 2007 Feb; 274(4):1110-22. PubMed ID: 17257267
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of oxidation-responsive alginate-deferoxamine conjugates with increased stability and low toxicity.
Tian M; Chen X; Gu Z; Li H; Ma L; Qi X; Tan H; You C
Carbohydr Polym; 2016 Jun; 144():522-30. PubMed ID: 27083844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
